Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Case Study: Manufacturing iPSC-derived skeletal muscle cells
Research highlights: Human iPSC-derived cardiomyocytes to study inherited cardiac arrhythmias
Expert Insights: iPSC-derived cardiomyocytes for cardiac drug discovery
Research highlights: Human iPSC technology can help reduce the gap between preclinical and clinical studies
User guide: Ncyte Cardiomyocytes
Expert Insights: Flexible solutions to meet our clients' needs